Skip to content
November 03, 2026

Equity.Guru

Investment information for the new generation

Search

Pharmaceuticals

18 April 2024 Revive Therapeutics (RVV.CN) announces FDA acceptance of meeting request…
18 April 2024
Revive Therapeutics (RVV.CN) announces FDA acceptance of meeting request
Revive Therapeutics (RVV.V) is a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders. The company offers cannabinoid pharmaceutical portfolio that…
2 April 2024 Revive Therapeutics (RVV.CN) updates on psilocybin study for methamphetamine…
2 April 2024
Revive Therapeutics (RVV.CN) updates on psilocybin study for methamphetamine use
Revive Therapeutics (RVV.V) is a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders. The company offers cannabinoid pharmaceutical portfolio that…
28 March 2024 Alpha Cognition Inc (ACOG.C) has navigated the Alzheimers FDA…
28 March 2024
Alpha Cognition Inc (ACOG.C) has navigated the Alzheimers FDA process…
People really don’t like pharma companies in Canada. We’ve had some monster megacorporations come out of Canada in the pharma space, and the biotech space, and a lot of…
27 March 2024 Revive Therapeutics (RVV.CN) submits package to FDA for long…
27 March 2024
Revive Therapeutics (RVV.CN) submits package to FDA for long term…
Revive Therapeutics (RVV.V) is a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders. The company offers cannabinoid pharmaceutical portfolio that…
26 March 2024 Medexus (MDP.TO) announces FDA approval for IXINITY to treat…
26 March 2024
Medexus (MDP.TO) announces FDA approval for IXINITY to treat hemophilia…
Specialty pharmaceuticals is a unique niche in the pharma sector. Where companies like Eli Lilly pour billions into developing a drug candidate from scratch with the very real possibility…
19 March 2024 Revive Therapeutics (RVV.CN) to submit meeting request with FDA…
19 March 2024
Revive Therapeutics (RVV.CN) to submit meeting request with FDA for…
Revive Therapeutics (RVV.V) is a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders. The company offers cannabinoid pharmaceutical portfolio that…
13 March 2024 Explaining biotech: Bionxt Solutions (BNXT.C) advances MS product through…
13 March 2024
Explaining biotech: Bionxt Solutions (BNXT.C) advances MS product through animal…
Bionxt Solutions Inc. (BNXT.C) has finished a study on a new type of medicine strip that dissolves in your mouth. This strip is designed to treat multiple sclerosis (MS),…
13 February 2024 Lophos Pharma (MESC.C) now readies for natural and synthetic…
13 February 2024
Lophos Pharma (MESC.C) now readies for natural and synthetic peyote…
Lophos Pharmaceuticals Corp. (MESC.C), a key player in the Canadian biosciences/psychedelics sector, has made a significant leap forward in the field of psychoactive compound research and development as it…
8 February 2024 Medexus (MDP.TO) stock drops hard on Q3 2024 results…
8 February 2024
Medexus (MDP.TO) stock drops hard on Q3 2024 results
Specialty pharmaceuticals is a unique niche in the pharma sector. Where companies like Eli Lilly pour billions into developing a drug candidate from scratch with the very real possibility…
2 February 2024 Revive Therapeutics (RVV.C) takes on long covid with new…
2 February 2024
Revive Therapeutics (RVV.C) takes on long covid with new phase…
Allow me to back into the lede a bit here. THE STORY OF ROCKERFELLER VS THE WORMS In the early part of the 20th century, the American South was…